|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
|
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
| Income Statement [Abstract] | ||||
| Product | $ 2,161,753 | $ 1,632,160 | $ 5,481,365 | $ 4,760,120 |
| Recurring | 1,127,025 | 1,162,559 | 3,197,925 | 3,445,234 |
| Total Net Revenue | 3,288,778 | 2,794,719 | 8,679,290 | 8,205,354 |
| Cost of Sales: | ||||
| Product | 1,166,848 | 1,002,816 | 2,969,512 | 2,728,980 |
| Recurring | 292,264 | 294,846 | 858,988 | 849,962 |
| Total Cost of Sales | 1,459,112 | 1,297,662 | 3,828,500 | 3,578,942 |
| Gross Profit | 1,829,666 | 1,497,057 | 4,850,790 | 4,626,412 |
| Research and development | 251,089 | 197,674 | 732,154 | 588,908 |
| Selling, general and administrative | 1,009,814 | 1,194,156 | 3,937,522 | 3,488,802 |
| Depreciation and amortization | 63,265 | 72,463 | 197,341 | 202,809 |
| Total Operating Expense | 1,324,168 | 1,464,293 | 4,867,017 | 4,280,519 |
| Income (Loss) from Operations | 505,498 | 32,764 | (16,227) | 345,893 |
| Other Income (Expenses): | ||||
| Interest (expense) income, net | 7,712 | (23,428) | (57,611) | (237,402) |
| Gain on derivative liability | 0 | 0 | 0 | 172,476 |
| Gain on disposal of property and equipment | 0 | 0 | 0 | 2,165 |
| Gain on sale of product line | 0 | 0 | 15,408 | 829,296 |
| Total Other Income (Expense) | 7,712 | (23,428) | (42,203) | 766,535 |
| Income (Loss) Before Provision for Income Taxes | 513,210 | 9,336 | (58,430) | 1,112,428 |
| Provision for Income Taxes | 0 | 0 | 0 | 0 |
| Net Income (Loss) | 513,210 | 9,336 | (58,430) | 1,112,428 |
| Accretion of preferred dividends and discount | (308,386) | (194,324) | (723,252) | (508,191) |
| Net income (loss) attributable to common stockholders | $ 204,824 | $ (184,988) | $ (781,682) | $ 604,237 |
| Income (loss) per common share - basic | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.01 |
| Income (loss) per common share - diluted | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.01 |
| Weighted Average Common Shares Outstanding - basic | 106,153,192 | 102,970,585 | 105,011,687 | 102,033,143 |
| Weighted Average Common Shares Outstanding - diluted | 107,611,189 | 104,399,613 | 106,469,685 | 103,462,171 |
| X | ||||||||||
|
- Definition
No authoritative reference available. No definition available.
|
| X | ||||||||||
|
- Definition
No authoritative reference available. No definition available.
|
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Costs incurred in production of other products during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents interest incurred for borrowed money which was used to produce goods or render services. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The gains and losses included in earning resulting from the sale of a project. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The difference between the sale price or salvage price and the book value of a property, plant, and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
Other preferred stock dividends and adjustments, not otherwise defined in the taxonomy, that are necessary to adjust net income to obtain net income applicable to common stockholders. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The total amount of other income recognized during the period not separately disclosed that is recurring in nature. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Revenue not otherwise defined in the taxonomy from the sale of manufactured products. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|